Trademarkia Logo

Canada

C$
GLENMARK DESIGN
REGISTERED

on 13 Aug 2019

Last Applicant/ Owned by

GLENMARK PHARMACEUTICALS LIMITED

B/2, Mahalaxmi Chambers22, Bhulabhai Desai RoadMumbai - 400 026

IN

Serial Number

1618754 filed on 18th Mar 2013

Registration Number

TMA1048628 registered on 13th Aug 2019

Registration expiry Date

13th Aug 2029

Correspondent Address

DEETH WILLIAMS WALL LLP

150 YORK STREET, SUITE 400TORONTO

ONTARIO

CA

M5H3S5

GLENMARK DESIGN

Trademark usage description

opium alkaloid preparations for the treatment of chronic pain; pharmaceutical anti-allergic preparations; pharmaceutical antitussive-cold preparations Read More

Classification Information


Class [005]
Opium alkaloid preparations for the treatment of chronic pain; Pharmaceutical anti-allergic preparations; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, spinal cord diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases and intermittent claudication; Pharmaceutical preparations for the treatment of gastro-intestinal diseases including diarrhea; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care, namely, creams, gels, lotions, body washes, antibiotic creams and ointments for the treatment of dry skin, Psoriasis, eczema, acne and allergies; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease and intermittent claudication; Pharmaceutical preparations for the prevention and treatment of disorders of the immune system, namely, autoimmune diseases and immunologic deficiency syndromes; Pharmaceutical preparations for the prevention and treatment of disorders of the cardio-vascular system; Pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, namely, diabetes, bulimia nervosa, anorexia, obesity, hypothyroidism and hypoglycemia; Pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; Pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, bone fractures, sprains and cartilage injuries; Pharmaceutical preparations for the prevention and treatment of disorders of the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical preparations for the treatment of inflammatory disorders, namely, inflammation of alimentary canal bowel diseases and inflammatory connective tissue diseases; Pharmaceutical preparations for use in dermatology, namely, for the treatment of dermatitis, skin pigmentation diseases, eczema, acne and psoriasis; Pharmaceutical preparations for use in oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, namely, bacterial skin infections, bacterial enteritis, pneumonia, respiratory tract infections, infections of the alimentary canal, infections of the eyes, nose, ears and mouth and ulcers; and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections and skin infections; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and a drug delivery system comprising polymerbased oral tablets for the continuous release of a wide variety of therapeutic agents, for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymerbased oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations against dry skin caused by pregnancy; Pharmaceutical preparations for chloasma; Pharmaceutical preparations for hydrating the skin during pregnancy; Pharmaceutical preparations for pregnancy blemishes; Pharmaceutical preparations for preventing skin blemishes during pregnancy; Pharmaceutical preparations to prevent stretch marks; Pharmaceutical preparations to prevent swelling in the legs; Pharmaceutical preparations for ophthalmological use; Pharmaceutical preparations for the treatment of dermatitis and skin pigmentation diseases for animals; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for the treatment of joint disease; Pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), and for the treatment of infectious diseases, namely, respiratory infections, eye infections and skin infections; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for treating respiratory diseases and asthma; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Preparation for the relief of pain; Preparations for the treatment of asthma


Classification kind code

11

Mark Details


Serial Number

1618754

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 24th Apr 2015
Allowed
Submitted for opposition 51
on 24th Apr 2015
Allowance Notice Sent
Submitted for opposition 42
on 7th Jan 2015
Advertised
Submitted for opposition 26
on 18th Dec 2014
Approved
Submitted for opposition 27
on 27th Oct 2014
Approval Notice Sent
Submitted for opposition 22
on 2th Dec 2013
Search Recorded
Submitted for opposition 20
on 2th Dec 2013
Examiner's First Report
Submitted for opposition 31
on 25th Mar 2013
Formalized
Submitted for opposition 1
on 19th Mar 2013
Created
Submitted for opposition 30
on 18th Mar 2013
Filed